James E AllisonSummaryAffiliation: Kaiser Permanente Country: USA Publications
|
Detail Information
Publications
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristicsJames E Allison
Division of Research, Kaiser Permanente Northern California Region, 2000 Broadway, Oakland, CA 94612 2304, USA
J Natl Cancer Inst 99:1462-70. 2007..Thus, improving the sensitivity of FOBT should make colon cancer screening programs that use these tests more effective...
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010Lisa J Herrinton
Kaiser Permanente Northern California, Oakland, CA, USA
Gastroenterology 143:382-9. 2012..The relationship between inflammatory bowel disease (IBD) and the incidence and mortality of colorectal adenocarcinoma (CRC) has not been evaluated recently...- FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a changeJames E Allison
Division of Research, Kaiser Permanente, Northern California, Oakland, California, USA
Am J Gastroenterol 105:2026-8. 2010.... - Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensingsLisa J Herrinton
Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
Inflamm Bowel Dis 13:451-61. 2007..There are few contemporary estimates of prevalence rates for inflammatory bowel disease (IBD) in diverse North American communities... - Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005Lisa J Herrinton
Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
Gastroenterology 137:502-11. 2009..The management of inflammatory bowel disease (IBD) has become increasingly complicated, and it is unknown whether poor outcomes (prolonged steroid use, hospitalizations, and surgery) have declined in the general population... - Immunochemical fecal occult blood tests for colorectal cancer screeningJames E Allison
Am J Med 116:498; author reply 498-9. 2004 - Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FITJames E Allison
Gastroenterology 129:745-8. 2005 - Screening tests for colorectal cancer: a menu of options remains relevantJames E Allison
University of California San Francisco, San Francisco General Hospital Campus, NH 3D, San Francisco, CA 94110, USA
Curr Oncol Rep 8:492-8. 2006..In this review we discuss the rationale for caution in designating one screening test as "the best" and present information on how new stool and serum tests can be used effectively to screen for CRC... - Stool DNA and occult blood testing for screen detection of colorectal neoplasiaDavid A Ahlquist
Mayo Clinic, Rochester, Minnesota 55905, USA
Ann Intern Med 149:441-50, W81. 2008..Stool DNA testing is a new approach to colorectal cancer detection. Few data are available from the screening setting...